- Report
- January 2022
- 88 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Osphena is a drug used to treat dyspareunia, a condition characterized by painful sexual intercourse in postmenopausal women. It is a selective estrogen receptor modulator (SERM) that works by restoring the natural balance of estrogen in the body. Osphena is the only FDA-approved drug specifically for this condition. It is used to reduce pain and improve sexual satisfaction.
Osphena is part of the Sexual and Reproductive Health Drugs market, which includes drugs used to treat conditions related to sexual health, fertility, and contraception. These drugs are used to treat a variety of conditions, including infertility, endometriosis, and menopause. They are also used to prevent pregnancy and to treat sexually transmitted infections.
Some companies in the Osphena market include Shionogi, Inc., Allergan, Inc., and Bayer AG. Show Less Read more